Vivjoa (oteseconazole) is an fda-approved antifungal medication to reduce yeast infections in people with vaginal yeast infections that keep coming back, also known as recurrent vulvovaginal candidiasis (RVVC). The medication shouldn't be taken by those who can get pregnant because it might cause harm to unborn babies, especially since it stays in your body for around 2 years after the last dose. Common side effects include headache and nausea. It's only available as a brand-name medication.
Recurrent vulvovaginal candidiasis (chronic vaginal yeast infection) in people who can't get pregnant
Vivjoa (oteseconazole) is an azole antifungal medication that kills the fungus that causes yeast infections. It does so by blocking the fungus from making an important substance needed for its outer protective layer. It also kills the fungus by causing a toxic substance to build up inside of it.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
First FDA-approved medication for RVVC
Only taken once per day or once per week
Works well up to almost a year after starting treatment
Doesn't interact with as many medications compared to similar medications
Available as a brand-name medication only
Can't be used in people who are able to become pregnant
Not recommended in people with severe kidney or liver problems
Must be taken with food in order to work fully
The dosing schedule for Vivjoa (oteseconazole) can be confusing. Keep track of the days on your calendar when taking the medication, since you'll start taking it daily and then move to once a week dosing.
Take Vivjoa (oteseconazole) with food to help it get absorbed better, and swallow the Vivjoa (oteseconazole) capsules whole. Don't crush, chew, open, or dissolve the capsules, since this could damage the medication or prevent you from getting your full dose.
Vivjoa (oteseconazole) can raise the levels of some medications if taken together, like rosuvastatin (Crestor). This can lead to more side effects from the other medication. Make sure to tell your prescriber all of the medications you're taking before starting Vivjoa (oteseconazole).
Don't stop taking Vivjoa (oteseconazole) suddenly without speaking with your prescriber first, even if you begin to feel better. Stopping too early can cause yeast infections to come back stronger.
To help prevent yeast infections, a few things you can do include wearing cotton underwear, changing out of wet swimsuits and workout clothes as soon as possible, and avoiding certain scented products.
Vivjoa (oteseconazole) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
People who are of reproductive potential (able to get pregnant), pregnant, or breastfeeding shouldn't take Vivjoa (oteseconazole) because of the risks to unborn babies and breastfed infants. Based on animal studies, Vivjoa (oteseconazole) might cause eye damage including cataracts, trouble seeing, and bleeding in the eyes of unborn babies. The risk is high in those who can get pregnant because Vivjoa (oteseconazole) stays in the body for almost 2 years after taking the last dose. If you haven't gone through menopause or have had surgeries that prevent you from having children, or if you're currently pregnant or breastfeeding, speak with your prescriber about safe options to treat RVVC.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
18 capsules of 150mg | 1 carton | $3000.55 | $3000.55 |
Vivjoa (oteseconazole) is either taken by itself or after taking fluconazole (Diflucan). Your prescriber will help you decide the best option for you.
Vivjoa (oteseconazole) only - dosing lasts a total of 12 weeks
Day 1: Take 600 mg (4 capsules) by mouth once.
Day 2: Take 450 mg (3 capsules) by mouth once.
Starting on Day 14: Take 150 mg (1 capsule) by mouth once a week (every 7 days) for 11 weeks.
Vivjoa (oteseconazole) and fluconazole (Diflucan): - dosing lasts a total of 14 weeks
Day 1: Take 150 mg of fluconazole (Diflucan).
Day 4: Take 150 mg of fluconazole (Diflucan).
Day 7: Take 150 mg of fluconazole (Diflucan).
Days 14 through 20: Take 150 mg (1 capsule) of Vivjoa (oteseconazole) by mouth once a day.
Starting on Day 28: Take 150 mg (1 capsule) of Vivjoa (oteseconazole) by mouth once a week (every 7 days) for 11 weeks.
People who are able to become pregnant
Currently pregnant
Currently breastfeeding
Recurrent vulvovaginal candidiasis (chronic vaginal yeast infection) in people who can't get pregnant
Treatment of vaginal yeast infection
Relief of vaginal yeast infection symptoms (itching and irritation outside of the vagina)
Treatment of infections caused by Candida:
Prevention of Candida fungal infections for people having a bone marrow transplant
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Pregnancy Association. (n.d.). Yeast infection during pregnancy.
Centers for Disease Control and Prevention. (2021). Vulvovaginal candidiasis (VVC).
Mao, Q., et al. (2015). Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--An update. The AAPS Journal.
Mycovia Pharmaceuticals, Inc. (2024). Vivjoa- oteseconazole capsule [package insert]. DailyMed.
Mycovia Pharmaceuticals. (2022). FDA approves Mycovia Pharmaceuticals’ Vivjoa™ (oteseconazole), the first and only FDA-approved medication for recurrent vulvovaginal candidiasis (chronic yeast infection).
Sobel, J. D., et al. (2021). Oteseconazole: An advance in treatment of recurrent vulvovaginal candidiasis. Future Microbiology.
Sobel, J. D., et al. (2022). Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis. The New England Journal of Medicine Evidence.
U.S. Food and Drug Administration. (2024). Drug trials snapshots: Vivjoa.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.